Protonation of Pt(IV) Anticancer Complexes Assayed by Vibrational Ion Spectroscopy
ChemPlusChem · 2025
DOI: 10.1002/cplu.202400754 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemPlusChem, 2025. Verfasst von Davide Corinti und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Chimica e Tecnologie del Farmaco, Università di Roma "La Sapienza", P. le A. Moro 5, I-00185, Roma, Italy. Hauptthemen laut MEDLINE: Antineoplastic Agents, Protons, Organoplatinum Compounds, Coordination Complexes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sapienza Università di Roma.
Abstract (Originalsprache)
Platinum(IV) complexes are being studied as potential alternatives to traditional platinum(II)‐based chemotherapy drugs. They promise reduced side effects and potential for oral administration. In fact, a preliminary reduction in the cellular medium is recognized as a crucial step for activation. However, a deeper understanding of the protonation sites and substitution behavior of Pt(IV) complexes is needed, considering that ligand hydrolysis may compete with reduction‐mediated activation, particularly in acidic environments such as the stomach. In this study, we investigated protonated Pt(IV) complexes with equatorial ligands common to widely used Pt(II) drugs containing square planar geometry, such as cisplatin and carboplatin. The additional axial substituents in the octahedral coordination sphere of Pt(IV) include different combinations of hydroxido and acetato ligands. Mass spectrometry‐based methods, including collision‐induced dissociation (CID) and infrared multiple photon dissociation (IRMPD) spectroscopy, supported by density functional theory (DFT) calculations, were employed. Structural characterization revealed that protonation preferences are influenced by the type and position of the ligands. Notably, protonation is generally favored on the carboxylato ligands; however, the carboplatin‐derived complex exhibited a mixed population of protomers, highlighting the significance of both axial and equatorial ligand configurations in shaping the prototropic equilibria happening in solution.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dipartimento di Chimica e Tecnologie del Farmaco, Università di Roma "La Sapienza", P. le A. Moro 5, I-00185, Roma, Italy.
- Dipartimento per lo Sviluppo Sostenibile e la Transizione Ecologica, Università del Piemonte Orientale, Piazza S. Eusebio 5, 13100, Vercelli, Italy.
- Dipartimento di Scienze e Innovazione Tecnologica, Università del Piemonte Orientale, Viale T. Michel 11, 15121, Alessandria, Italy.
ORCID-Profile: Davide Corinti, Elisabetta Gabano, Barbara Chiavarino, Maria Elisa Crestoni, Domenico Osella, Simonetta Fornarini
Förderung
- Sapienza Università di Roma
Zitieren
APA
Corinti, D., Gabano, E., Chiavarino, B., Crestoni, M. E., Osella, D., & Fornarini, S. (2025). Protonation of Pt(IV) Anticancer Complexes Assayed by Vibrational Ion Spectroscopy. ChemPlusChem. https://doi.org/10.1002/cplu.202400754
Vancouver
Corinti D, Gabano E, Chiavarino B, Crestoni ME, Osella D, Fornarini S. Protonation of Pt(IV) Anticancer Complexes Assayed by Vibrational Ion Spectroscopy. ChemPlusChem. 2025. doi:10.1002/cplu.202400754
BibTeX
@article{Corinti2025,
author = {Corinti, Davide and Gabano, Elisabetta and Chiavarino, Barbara and Crestoni, Maria Elisa and Osella, Domenico and Fornarini, Simonetta},
title = {Protonation of Pt(IV) Anticancer Complexes Assayed by Vibrational Ion Spectroscopy},
journal = {ChemPlusChem},
year = {2025},
doi = {10.1002/cplu.202400754}
}
EUVIMED